Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

MCRI’s POSSUMweb and FDNA’s Face2Gene Announce Exclusive Integration to Improve Speed and Accuracy of Rare Disease Diagnosis

FDNA
Posted on: 11 Oct 17

Murdoch Children’s Research Institute (MCRI) and the Victorian Clinical Genetics Service (VCGS) has partnered with Boston-based FDNA for full integration and exclusive distribution of MCRI’s POSSUMweb database through FDNA’s Face2Gene suite of software applications. POSSUMweb’s database integration will assist clinicians in shortening the diagnostic timeline for patients by providing insights from over 4,000 syndromes, including multiple malformations, metabolic, teratogenic, chromosomal and skeletal syndromes.

“Partnering with FDNA greatly expands the reach of our data and image library, thanks to the widespread use of Face2Gene among healthcare providers,” said Professor Martin Delatycki of POSSUMweb. “To have such an expansive set of information in the hands of thousands of clinicians across the globe helps us achieve our goal of improving the speed and accuracy of diagnosing genetic malformations and syndromes.”

Face2Gene is a next-generation phenotyping application that uses facial analysis, artificial intelligence and deep learning to help clinicians discover possible syndromes, genetics or clinical features that may be impacting a patient’s health. With a majority of clinical geneticists globally using Face2Gene, it is the ideal access point for POSSUMweb’s database of 30,000 images including photos, x-rays, scans and diagrams, providing quickly accessible information for clinicians evaluating a patient. With POSSUMweb’s integration and FDNA’s existing partnership with London Medical Databases, Face2Gene LIBRARY is now the most comprehensive and trusted source of reference for genetic syndrome data and images in the world.

“Integration of POSSUMweb with Face2Gene vastly increases the amount of data, images and insights available to our users,” said Dekel Gelbman, CEO, FDNA. “Instant reference capabilities will help clinicians greatly shorten the diagnostic journey for patients struggling with undiagnosed genetic diseases.”

Relevant insights from POSSUMweb will be made available to clinicians through the Face2Gene application for patient evaluations, and the more robust and searchable content from POSSUMweb will be accessible through Face2Gene LIBRARY to POSSUMweb subscribed users.

About POSSUMWeb
POSSUMweb is a dysmorphology database that can assist with diagnosis of syndromes in patients and is a valuable teaching and research tool. The POSSUM database (Pictures Of Standard Syndromes and Undiagnosed Malformations) was developed at the Murdoch Children’s Research Institute in conjunction with the Victorian Clinical Genetics Service and Royal Children’s Hospital in Melbourne, Australia and has been used by clinicians for more than 30 years. With constant updating, and nearly 5,000 syndromes and over 40,000 images, it has been valued as an essential diagnostic tool worldwide. The latest web-based version not only allows searching by traits, syndrome names or free text, but has direct links to PubMed, OMIM, and free on-line articles. There is an extensive illustrated trait dictionary, particularly useful to those new to dysmorphology.

About FDNA and Face2Gene
FDNA is the developer of Face2Gene, a clinical suite of phenotyping applications that facilitates comprehensive and precise genetic evaluations. Face2Gene uses facial analysis, deep learning and artificial intelligence to transform big data into actionable genomic insights to improve and accelerate diagnostics and therapeutics. With the world’s largest network of clinicians, labs and researchers creating one of the fastest growing and most comprehensive genomic databases, FDNA is changing the lives of rare disease patients. For more information, visit www.FDNA.com . Face2Gene is a registered trademark of FDNA INC.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171011005061/en/

Business Wire
www.businesswire.com

Last updated on: 11/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.